Revvity (RVTY) EBT Growth (3y) (2012 - 2026)
Revvity (RVTY) EBT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -36.31% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.36% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.75% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 9.91% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 2.67% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 14.73% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -3.23% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 58.91% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -2.56% |
| 10 | Revvity | 11.63 Bn | 10.77 Bn | 387.66 Mn | 19.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 19.30% |
| Dec 28, 2025 | -12.88% |
| Sep 28, 2025 | -12.15% |
| Jun 29, 2025 | -30.71% |
| Mar 30, 2025 | -38.47% |
| Dec 29, 2024 | -31.92% |
| Sep 29, 2024 | -9.41% |
| Jun 30, 2024 | -33.99% |
| Mar 31, 2024 | -58.04% |
| Oct 1, 2023 | -39.96% |
| Jul 2, 2023 | -24.28% |
| Apr 2, 2023 | -5.32% |
| Jan 1, 2023 | 28.47% |
| Oct 2, 2022 | 9.10% |
| Jul 3, 2022 | 42.16% |
| Apr 3, 2022 | 82.89% |
| Jan 2, 2022 | 55.68% |
| Oct 3, 2021 | 20.05% |
| Jul 4, 2021 | 61.37% |
| Apr 4, 2021 | 154.08% |